机构风向标 | 安旭生物(688075)2025年三季度已披露持仓机构仅5家

Core Viewpoint - Anxu Bio (688075.SH) reported its Q3 2025 results, highlighting a significant presence of institutional investors holding 39.66% of its total shares, with a slight decrease in institutional ownership compared to the previous quarter [1] Institutional Investors - As of October 30, 2025, five institutional investors disclosed holdings in Anxu Bio, totaling 50.3993 million shares, which represents 39.66% of the company's total share capital [1] - The institutional ownership decreased by 0.19 percentage points compared to the previous quarter [1] Public Funds - Two public funds increased their holdings during this period, namely Guangfa Value Core Mixed A and Xinyuan Specialized and New Mixed A, with an increase in holdings accounting for 0.44% [1] - A total of 46 public funds did not disclose their holdings this quarter, including notable funds such as Bosera Phoenix Leading Mixed A and Morgan Stanley Multi-Factor Strategy Mixed [1]